nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobazam—ABCB1—ovarian cancer	0.446	1	CbGaD
Clobazam—ABCB1—Topotecan—ovarian cancer	0.0631	0.199	CbGbCtD
Clobazam—ABCB1—Vinorelbine—ovarian cancer	0.0445	0.14	CbGbCtD
Clobazam—CYP3A4—Topotecan—ovarian cancer	0.0378	0.119	CbGbCtD
Clobazam—CYP2B6—Doxorubicin—ovarian cancer	0.0328	0.103	CbGbCtD
Clobazam—ABCB1—Paclitaxel—ovarian cancer	0.0312	0.0983	CbGbCtD
Clobazam—CYP3A4—Vinorelbine—ovarian cancer	0.0266	0.0838	CbGbCtD
Clobazam—ABCB1—Docetaxel—ovarian cancer	0.0226	0.0711	CbGbCtD
Clobazam—CYP3A4—Paclitaxel—ovarian cancer	0.0187	0.0589	CbGbCtD
Clobazam—ABCB1—Doxorubicin—ovarian cancer	0.0168	0.053	CbGbCtD
Clobazam—CYP3A4—Docetaxel—ovarian cancer	0.0135	0.0426	CbGbCtD
Clobazam—CYP3A4—Doxorubicin—ovarian cancer	0.0101	0.0317	CbGbCtD
Clobazam—Erythema multiforme—Paclitaxel—ovarian cancer	0.000502	0.00262	CcSEcCtD
Clobazam—Infestation NOS—Docetaxel—ovarian cancer	0.000501	0.00261	CcSEcCtD
Clobazam—Infestation—Docetaxel—ovarian cancer	0.000501	0.00261	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000497	0.00259	CcSEcCtD
Clobazam—Eye disorder—Paclitaxel—ovarian cancer	0.000496	0.00259	CcSEcCtD
Clobazam—Decreased appetite—Vinorelbine—ovarian cancer	0.000487	0.00254	CcSEcCtD
Clobazam—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000484	0.00252	CcSEcCtD
Clobazam—Fatigue—Vinorelbine—ovarian cancer	0.000483	0.00252	CcSEcCtD
Clobazam—Constipation—Vinorelbine—ovarian cancer	0.000479	0.0025	CcSEcCtD
Clobazam—Asthenia—Topotecan—ovarian cancer	0.00047	0.00245	CcSEcCtD
Clobazam—Vomiting—Chlorambucil—ovarian cancer	0.000468	0.00244	CcSEcCtD
Clobazam—Increased appetite—Epirubicin—ovarian cancer	0.000467	0.00244	CcSEcCtD
Clobazam—Mental disorder—Paclitaxel—ovarian cancer	0.000465	0.00243	CcSEcCtD
Clobazam—Pruritus—Topotecan—ovarian cancer	0.000463	0.00242	CcSEcCtD
Clobazam—Malnutrition—Paclitaxel—ovarian cancer	0.000462	0.00241	CcSEcCtD
Clobazam—Feeling abnormal—Vinorelbine—ovarian cancer	0.000462	0.00241	CcSEcCtD
Clobazam—Asthenia—Melphalan—ovarian cancer	0.00046	0.0024	CcSEcCtD
Clobazam—Pruritus—Melphalan—ovarian cancer	0.000454	0.00237	CcSEcCtD
Clobazam—Tension—Paclitaxel—ovarian cancer	0.000453	0.00236	CcSEcCtD
Clobazam—Nervousness—Paclitaxel—ovarian cancer	0.000448	0.00234	CcSEcCtD
Clobazam—Diarrhoea—Topotecan—ovarian cancer	0.000448	0.00234	CcSEcCtD
Clobazam—Lethargy—Epirubicin—ovarian cancer	0.000447	0.00233	CcSEcCtD
Clobazam—Urticaria—Vinorelbine—ovarian cancer	0.000445	0.00232	CcSEcCtD
Clobazam—Muscle spasms—Paclitaxel—ovarian cancer	0.000444	0.00232	CcSEcCtD
Clobazam—Body temperature increased—Vinorelbine—ovarian cancer	0.000443	0.00231	CcSEcCtD
Clobazam—Diarrhoea—Melphalan—ovarian cancer	0.000439	0.00229	CcSEcCtD
Clobazam—Osteoarthritis—Epirubicin—ovarian cancer	0.000438	0.00229	CcSEcCtD
Clobazam—Diplopia—Epirubicin—ovarian cancer	0.000438	0.00229	CcSEcCtD
Clobazam—Nausea—Chlorambucil—ovarian cancer	0.000437	0.00228	CcSEcCtD
Clobazam—Vision blurred—Paclitaxel—ovarian cancer	0.000435	0.00227	CcSEcCtD
Clobazam—Visual impairment—Docetaxel—ovarian cancer	0.000433	0.00226	CcSEcCtD
Clobazam—Dizziness—Topotecan—ovarian cancer	0.000433	0.00226	CcSEcCtD
Clobazam—Tremor—Paclitaxel—ovarian cancer	0.000433	0.00226	CcSEcCtD
Clobazam—Increased appetite—Doxorubicin—ovarian cancer	0.000432	0.00225	CcSEcCtD
Clobazam—Anaemia—Paclitaxel—ovarian cancer	0.000427	0.00223	CcSEcCtD
Clobazam—Erythema multiforme—Docetaxel—ovarian cancer	0.000425	0.00222	CcSEcCtD
Clobazam—Agitation—Paclitaxel—ovarian cancer	0.000424	0.00221	CcSEcCtD
Clobazam—Eye disorder—Docetaxel—ovarian cancer	0.00042	0.00219	CcSEcCtD
Clobazam—Vomiting—Topotecan—ovarian cancer	0.000416	0.00217	CcSEcCtD
Clobazam—Lethargy—Doxorubicin—ovarian cancer	0.000414	0.00216	CcSEcCtD
Clobazam—Leukopenia—Paclitaxel—ovarian cancer	0.000413	0.00216	CcSEcCtD
Clobazam—Rash—Topotecan—ovarian cancer	0.000413	0.00216	CcSEcCtD
Clobazam—Dermatitis—Topotecan—ovarian cancer	0.000413	0.00215	CcSEcCtD
Clobazam—Ataxia—Epirubicin—ovarian cancer	0.000412	0.00215	CcSEcCtD
Clobazam—Headache—Topotecan—ovarian cancer	0.00041	0.00214	CcSEcCtD
Clobazam—Vomiting—Melphalan—ovarian cancer	0.000408	0.00213	CcSEcCtD
Clobazam—Diplopia—Doxorubicin—ovarian cancer	0.000406	0.00212	CcSEcCtD
Clobazam—Osteoarthritis—Doxorubicin—ovarian cancer	0.000406	0.00212	CcSEcCtD
Clobazam—Liver function test abnormal—Epirubicin—ovarian cancer	0.000405	0.00211	CcSEcCtD
Clobazam—Rash—Melphalan—ovarian cancer	0.000404	0.00211	CcSEcCtD
Clobazam—Dermatitis—Melphalan—ovarian cancer	0.000404	0.00211	CcSEcCtD
Clobazam—Cough—Paclitaxel—ovarian cancer	0.000403	0.0021	CcSEcCtD
Clobazam—Asthenia—Vinorelbine—ovarian cancer	0.000402	0.0021	CcSEcCtD
Clobazam—Pruritus—Vinorelbine—ovarian cancer	0.000396	0.00207	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000395	0.00206	CcSEcCtD
Clobazam—Mental disorder—Docetaxel—ovarian cancer	0.000394	0.00206	CcSEcCtD
Clobazam—Myalgia—Paclitaxel—ovarian cancer	0.000393	0.00205	CcSEcCtD
Clobazam—Anxiety—Paclitaxel—ovarian cancer	0.000392	0.00204	CcSEcCtD
Clobazam—Malnutrition—Docetaxel—ovarian cancer	0.000391	0.00204	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00039	0.00204	CcSEcCtD
Clobazam—Nausea—Topotecan—ovarian cancer	0.000389	0.00203	CcSEcCtD
Clobazam—Muscular weakness—Epirubicin—ovarian cancer	0.000387	0.00202	CcSEcCtD
Clobazam—Dry mouth—Paclitaxel—ovarian cancer	0.000384	0.00201	CcSEcCtD
Clobazam—Diarrhoea—Vinorelbine—ovarian cancer	0.000383	0.002	CcSEcCtD
Clobazam—Abdominal distension—Epirubicin—ovarian cancer	0.000381	0.00199	CcSEcCtD
Clobazam—Ataxia—Doxorubicin—ovarian cancer	0.000381	0.00199	CcSEcCtD
Clobazam—Nausea—Melphalan—ovarian cancer	0.000381	0.00199	CcSEcCtD
Clobazam—Confusional state—Paclitaxel—ovarian cancer	0.00038	0.00198	CcSEcCtD
Clobazam—Asthma—Epirubicin—ovarian cancer	0.000379	0.00198	CcSEcCtD
Clobazam—Dysphagia—Epirubicin—ovarian cancer	0.000379	0.00198	CcSEcCtD
Clobazam—Muscle spasms—Docetaxel—ovarian cancer	0.000376	0.00196	CcSEcCtD
Clobazam—Eosinophilia—Epirubicin—ovarian cancer	0.000375	0.00196	CcSEcCtD
Clobazam—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000374	0.00195	CcSEcCtD
Clobazam—Infection—Paclitaxel—ovarian cancer	0.000374	0.00195	CcSEcCtD
Clobazam—Dizziness—Vinorelbine—ovarian cancer	0.000371	0.00193	CcSEcCtD
Clobazam—Nervous system disorder—Paclitaxel—ovarian cancer	0.00037	0.00193	CcSEcCtD
Clobazam—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000369	0.00193	CcSEcCtD
Clobazam—Skin disorder—Paclitaxel—ovarian cancer	0.000366	0.00191	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000365	0.00191	CcSEcCtD
Clobazam—Bronchitis—Epirubicin—ovarian cancer	0.000364	0.0019	CcSEcCtD
Clobazam—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000364	0.0019	CcSEcCtD
Clobazam—Anaemia—Docetaxel—ovarian cancer	0.000362	0.00189	CcSEcCtD
Clobazam—Anorexia—Paclitaxel—ovarian cancer	0.000359	0.00187	CcSEcCtD
Clobazam—Muscular weakness—Doxorubicin—ovarian cancer	0.000358	0.00187	CcSEcCtD
Clobazam—Vomiting—Vinorelbine—ovarian cancer	0.000356	0.00186	CcSEcCtD
Clobazam—Rash—Vinorelbine—ovarian cancer	0.000353	0.00184	CcSEcCtD
Clobazam—Dermatitis—Vinorelbine—ovarian cancer	0.000353	0.00184	CcSEcCtD
Clobazam—Abdominal distension—Doxorubicin—ovarian cancer	0.000353	0.00184	CcSEcCtD
Clobazam—Hypotension—Paclitaxel—ovarian cancer	0.000352	0.00184	CcSEcCtD
Clobazam—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000352	0.00184	CcSEcCtD
Clobazam—Headache—Vinorelbine—ovarian cancer	0.000351	0.00183	CcSEcCtD
Clobazam—Dysphagia—Doxorubicin—ovarian cancer	0.000351	0.00183	CcSEcCtD
Clobazam—Asthma—Doxorubicin—ovarian cancer	0.000351	0.00183	CcSEcCtD
Clobazam—Leukopenia—Docetaxel—ovarian cancer	0.00035	0.00183	CcSEcCtD
Clobazam—Eosinophilia—Doxorubicin—ovarian cancer	0.000347	0.00181	CcSEcCtD
Clobazam—Weight increased—Epirubicin—ovarian cancer	0.000345	0.0018	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000343	0.00179	CcSEcCtD
Clobazam—Cough—Docetaxel—ovarian cancer	0.000342	0.00178	CcSEcCtD
Clobazam—Insomnia—Paclitaxel—ovarian cancer	0.000341	0.00178	CcSEcCtD
Clobazam—Pneumonia—Epirubicin—ovarian cancer	0.00034	0.00177	CcSEcCtD
Clobazam—Infestation NOS—Epirubicin—ovarian cancer	0.000338	0.00176	CcSEcCtD
Clobazam—Infestation—Epirubicin—ovarian cancer	0.000338	0.00176	CcSEcCtD
Clobazam—Drowsiness—Epirubicin—ovarian cancer	0.000338	0.00176	CcSEcCtD
Clobazam—Bronchitis—Doxorubicin—ovarian cancer	0.000337	0.00176	CcSEcCtD
Clobazam—Somnolence—Paclitaxel—ovarian cancer	0.000335	0.00175	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000335	0.00175	CcSEcCtD
Clobazam—Myalgia—Docetaxel—ovarian cancer	0.000333	0.00174	CcSEcCtD
Clobazam—Nausea—Vinorelbine—ovarian cancer	0.000333	0.00174	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000331	0.00173	CcSEcCtD
Clobazam—Urinary tract infection—Epirubicin—ovarian cancer	0.000328	0.00171	CcSEcCtD
Clobazam—Decreased appetite—Paclitaxel—ovarian cancer	0.000328	0.00171	CcSEcCtD
Clobazam—Dry mouth—Docetaxel—ovarian cancer	0.000326	0.0017	CcSEcCtD
Clobazam—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000326	0.0017	CcSEcCtD
Clobazam—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000325	0.0017	CcSEcCtD
Clobazam—Fatigue—Paclitaxel—ovarian cancer	0.000325	0.0017	CcSEcCtD
Clobazam—Sweating—Epirubicin—ovarian cancer	0.000324	0.00169	CcSEcCtD
Clobazam—Constipation—Paclitaxel—ovarian cancer	0.000322	0.00168	CcSEcCtD
Clobazam—Confusional state—Docetaxel—ovarian cancer	0.000322	0.00168	CcSEcCtD
Clobazam—Weight increased—Doxorubicin—ovarian cancer	0.000319	0.00167	CcSEcCtD
Clobazam—Infection—Docetaxel—ovarian cancer	0.000317	0.00166	CcSEcCtD
Clobazam—Pneumonia—Doxorubicin—ovarian cancer	0.000314	0.00164	CcSEcCtD
Clobazam—Nervous system disorder—Docetaxel—ovarian cancer	0.000313	0.00163	CcSEcCtD
Clobazam—Thrombocytopenia—Docetaxel—ovarian cancer	0.000313	0.00163	CcSEcCtD
Clobazam—Infestation NOS—Doxorubicin—ovarian cancer	0.000313	0.00163	CcSEcCtD
Clobazam—Infestation—Doxorubicin—ovarian cancer	0.000313	0.00163	CcSEcCtD
Clobazam—Drowsiness—Doxorubicin—ovarian cancer	0.000313	0.00163	CcSEcCtD
Clobazam—Feeling abnormal—Paclitaxel—ovarian cancer	0.000311	0.00162	CcSEcCtD
Clobazam—Skin disorder—Docetaxel—ovarian cancer	0.00031	0.00162	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00031	0.00162	CcSEcCtD
Clobazam—Anorexia—Docetaxel—ovarian cancer	0.000304	0.00159	CcSEcCtD
Clobazam—Urinary tract infection—Doxorubicin—ovarian cancer	0.000304	0.00159	CcSEcCtD
Clobazam—Sweating—Doxorubicin—ovarian cancer	0.0003	0.00156	CcSEcCtD
Clobazam—Urticaria—Paclitaxel—ovarian cancer	0.000299	0.00156	CcSEcCtD
Clobazam—Hypotension—Docetaxel—ovarian cancer	0.000298	0.00156	CcSEcCtD
Clobazam—Body temperature increased—Paclitaxel—ovarian cancer	0.000298	0.00155	CcSEcCtD
Clobazam—Visual impairment—Epirubicin—ovarian cancer	0.000292	0.00153	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000291	0.00152	CcSEcCtD
Clobazam—Insomnia—Docetaxel—ovarian cancer	0.000289	0.00151	CcSEcCtD
Clobazam—Erythema multiforme—Epirubicin—ovarian cancer	0.000287	0.0015	CcSEcCtD
Clobazam—Somnolence—Docetaxel—ovarian cancer	0.000284	0.00148	CcSEcCtD
Clobazam—Eye disorder—Epirubicin—ovarian cancer	0.000283	0.00148	CcSEcCtD
Clobazam—Decreased appetite—Docetaxel—ovarian cancer	0.000278	0.00145	CcSEcCtD
Clobazam—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000276	0.00144	CcSEcCtD
Clobazam—Fatigue—Docetaxel—ovarian cancer	0.000275	0.00144	CcSEcCtD
Clobazam—Constipation—Docetaxel—ovarian cancer	0.000273	0.00143	CcSEcCtD
Clobazam—Visual impairment—Doxorubicin—ovarian cancer	0.00027	0.00141	CcSEcCtD
Clobazam—Asthenia—Paclitaxel—ovarian cancer	0.00027	0.00141	CcSEcCtD
Clobazam—Pruritus—Paclitaxel—ovarian cancer	0.000267	0.00139	CcSEcCtD
Clobazam—Mental disorder—Epirubicin—ovarian cancer	0.000266	0.00139	CcSEcCtD
Clobazam—Erythema multiforme—Doxorubicin—ovarian cancer	0.000265	0.00138	CcSEcCtD
Clobazam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000265	0.00593	CbGpPWpGaD
Clobazam—Malnutrition—Epirubicin—ovarian cancer	0.000264	0.00138	CcSEcCtD
Clobazam—Feeling abnormal—Docetaxel—ovarian cancer	0.000263	0.00137	CcSEcCtD
Clobazam—Eye disorder—Doxorubicin—ovarian cancer	0.000262	0.00137	CcSEcCtD
Clobazam—GABRB2—Neuronal System—NSF—ovarian cancer	0.000259	0.00581	CbGpPWpGaD
Clobazam—Tension—Epirubicin—ovarian cancer	0.000259	0.00135	CcSEcCtD
Clobazam—Diarrhoea—Paclitaxel—ovarian cancer	0.000258	0.00135	CcSEcCtD
Clobazam—Nervousness—Epirubicin—ovarian cancer	0.000256	0.00134	CcSEcCtD
Clobazam—Muscle spasms—Epirubicin—ovarian cancer	0.000254	0.00132	CcSEcCtD
Clobazam—Body temperature increased—Docetaxel—ovarian cancer	0.000253	0.00132	CcSEcCtD
Clobazam—Dizziness—Paclitaxel—ovarian cancer	0.000249	0.0013	CcSEcCtD
Clobazam—Vision blurred—Epirubicin—ovarian cancer	0.000249	0.0013	CcSEcCtD
Clobazam—Mental disorder—Doxorubicin—ovarian cancer	0.000246	0.00128	CcSEcCtD
Clobazam—Malnutrition—Doxorubicin—ovarian cancer	0.000244	0.00127	CcSEcCtD
Clobazam—Anaemia—Epirubicin—ovarian cancer	0.000244	0.00127	CcSEcCtD
Clobazam—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.000243	0.00544	CbGpPWpGaD
Clobazam—Agitation—Epirubicin—ovarian cancer	0.000243	0.00127	CcSEcCtD
Clobazam—Tension—Doxorubicin—ovarian cancer	0.00024	0.00125	CcSEcCtD
Clobazam—Vomiting—Paclitaxel—ovarian cancer	0.00024	0.00125	CcSEcCtD
Clobazam—Rash—Paclitaxel—ovarian cancer	0.000238	0.00124	CcSEcCtD
Clobazam—Dermatitis—Paclitaxel—ovarian cancer	0.000237	0.00124	CcSEcCtD
Clobazam—Nervousness—Doxorubicin—ovarian cancer	0.000237	0.00124	CcSEcCtD
Clobazam—GABRG2—Neuronal System—NSF—ovarian cancer	0.000237	0.00531	CbGpPWpGaD
Clobazam—Leukopenia—Epirubicin—ovarian cancer	0.000236	0.00123	CcSEcCtD
Clobazam—Headache—Paclitaxel—ovarian cancer	0.000236	0.00123	CcSEcCtD
Clobazam—Muscle spasms—Doxorubicin—ovarian cancer	0.000235	0.00123	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000234	0.00523	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—CYTB—ovarian cancer	0.000233	0.00522	CbGpPWpGaD
Clobazam—Cough—Epirubicin—ovarian cancer	0.00023	0.0012	CcSEcCtD
Clobazam—Vision blurred—Doxorubicin—ovarian cancer	0.00023	0.0012	CcSEcCtD
Clobazam—Asthenia—Docetaxel—ovarian cancer	0.000229	0.0012	CcSEcCtD
Clobazam—CYP2C18—FOXA1 transcription factor network—CDKN1B—ovarian cancer	0.000227	0.00509	CbGpPWpGaD
Clobazam—Pruritus—Docetaxel—ovarian cancer	0.000226	0.00118	CcSEcCtD
Clobazam—Anaemia—Doxorubicin—ovarian cancer	0.000226	0.00118	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000226	0.00506	CbGpPWpGaD
Clobazam—Myalgia—Epirubicin—ovarian cancer	0.000225	0.00117	CcSEcCtD
Clobazam—Agitation—Doxorubicin—ovarian cancer	0.000224	0.00117	CcSEcCtD
Clobazam—Anxiety—Epirubicin—ovarian cancer	0.000224	0.00117	CcSEcCtD
Clobazam—Nausea—Paclitaxel—ovarian cancer	0.000224	0.00117	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000223	0.00116	CcSEcCtD
Clobazam—Dry mouth—Epirubicin—ovarian cancer	0.00022	0.00115	CcSEcCtD
Clobazam—Leukopenia—Doxorubicin—ovarian cancer	0.000219	0.00114	CcSEcCtD
Clobazam—Diarrhoea—Docetaxel—ovarian cancer	0.000219	0.00114	CcSEcCtD
Clobazam—Confusional state—Epirubicin—ovarian cancer	0.000217	0.00113	CcSEcCtD
Clobazam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—ovarian cancer	0.000217	0.00486	CbGpPWpGaD
Clobazam—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000215	0.00481	CbGpPWpGaD
Clobazam—Infection—Epirubicin—ovarian cancer	0.000214	0.00112	CcSEcCtD
Clobazam—Cough—Doxorubicin—ovarian cancer	0.000213	0.00111	CcSEcCtD
Clobazam—Nervous system disorder—Epirubicin—ovarian cancer	0.000211	0.0011	CcSEcCtD
Clobazam—Dizziness—Docetaxel—ovarian cancer	0.000211	0.0011	CcSEcCtD
Clobazam—Thrombocytopenia—Epirubicin—ovarian cancer	0.000211	0.0011	CcSEcCtD
Clobazam—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.00021	0.0047	CbGpPWpGaD
Clobazam—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000209	0.00469	CbGpPWpGaD
Clobazam—Skin disorder—Epirubicin—ovarian cancer	0.000209	0.00109	CcSEcCtD
Clobazam—Hyperhidrosis—Epirubicin—ovarian cancer	0.000208	0.00109	CcSEcCtD
Clobazam—Myalgia—Doxorubicin—ovarian cancer	0.000208	0.00109	CcSEcCtD
Clobazam—GABRA1—Neuronal System—NSF—ovarian cancer	0.000207	0.00464	CbGpPWpGaD
Clobazam—Anxiety—Doxorubicin—ovarian cancer	0.000207	0.00108	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000207	0.00108	CcSEcCtD
Clobazam—Anorexia—Epirubicin—ovarian cancer	0.000205	0.00107	CcSEcCtD
Clobazam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000204	0.00457	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—BRIP1—ovarian cancer	0.000203	0.00456	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PPP1CC—ovarian cancer	0.000203	0.00456	CbGpPWpGaD
Clobazam—Dry mouth—Doxorubicin—ovarian cancer	0.000203	0.00106	CcSEcCtD
Clobazam—Vomiting—Docetaxel—ovarian cancer	0.000203	0.00106	CcSEcCtD
Clobazam—Rash—Docetaxel—ovarian cancer	0.000201	0.00105	CcSEcCtD
Clobazam—CYP2B6—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000201	0.00451	CbGpPWpGaD
Clobazam—Hypotension—Epirubicin—ovarian cancer	0.000201	0.00105	CcSEcCtD
Clobazam—Dermatitis—Docetaxel—ovarian cancer	0.000201	0.00105	CcSEcCtD
Clobazam—Confusional state—Doxorubicin—ovarian cancer	0.000201	0.00105	CcSEcCtD
Clobazam—Headache—Docetaxel—ovarian cancer	0.0002	0.00104	CcSEcCtD
Clobazam—Infection—Doxorubicin—ovarian cancer	0.000198	0.00103	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000196	0.00102	CcSEcCtD
Clobazam—Nervous system disorder—Doxorubicin—ovarian cancer	0.000195	0.00102	CcSEcCtD
Clobazam—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000195	0.00102	CcSEcCtD
Clobazam—Insomnia—Epirubicin—ovarian cancer	0.000195	0.00102	CcSEcCtD
Clobazam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—ovarian cancer	0.000194	0.00435	CbGpPWpGaD
Clobazam—Skin disorder—Doxorubicin—ovarian cancer	0.000194	0.00101	CcSEcCtD
Clobazam—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000193	0.00101	CcSEcCtD
Clobazam—Somnolence—Epirubicin—ovarian cancer	0.000192	0.001	CcSEcCtD
Clobazam—Anorexia—Doxorubicin—ovarian cancer	0.00019	0.000992	CcSEcCtD
Clobazam—Nausea—Docetaxel—ovarian cancer	0.00019	0.00099	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000188	0.00422	CbGpPWpGaD
Clobazam—Decreased appetite—Epirubicin—ovarian cancer	0.000187	0.000977	CcSEcCtD
Clobazam—Hypotension—Doxorubicin—ovarian cancer	0.000186	0.000972	CcSEcCtD
Clobazam—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000186	0.000971	CcSEcCtD
Clobazam—Fatigue—Epirubicin—ovarian cancer	0.000186	0.000969	CcSEcCtD
Clobazam—Constipation—Epirubicin—ovarian cancer	0.000184	0.000962	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000182	0.00407	CbGpPWpGaD
Clobazam—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000182	0.000948	CcSEcCtD
Clobazam—Insomnia—Doxorubicin—ovarian cancer	0.00018	0.000941	CcSEcCtD
Clobazam—CYP2C18—Biological oxidations—CYP1B1—ovarian cancer	0.000179	0.004	CbGpPWpGaD
Clobazam—CYP2C19—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000178	0.004	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000178	0.00399	CbGpPWpGaD
Clobazam—Feeling abnormal—Epirubicin—ovarian cancer	0.000178	0.000927	CcSEcCtD
Clobazam—Somnolence—Doxorubicin—ovarian cancer	0.000177	0.000925	CcSEcCtD
Clobazam—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.000176	0.00395	CbGpPWpGaD
Clobazam—CYP2C18—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000176	0.00395	CbGpPWpGaD
Clobazam—Decreased appetite—Doxorubicin—ovarian cancer	0.000173	0.000904	CcSEcCtD
Clobazam—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000172	0.000898	CcSEcCtD
Clobazam—Fatigue—Doxorubicin—ovarian cancer	0.000172	0.000897	CcSEcCtD
Clobazam—Urticaria—Epirubicin—ovarian cancer	0.000171	0.000893	CcSEcCtD
Clobazam—Constipation—Doxorubicin—ovarian cancer	0.00017	0.00089	CcSEcCtD
Clobazam—Body temperature increased—Epirubicin—ovarian cancer	0.00017	0.000889	CcSEcCtD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.000168	0.00376	CbGpPWpGaD
Clobazam—SLC6A11—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000168	0.00376	CbGpPWpGaD
Clobazam—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000165	0.00371	CbGpPWpGaD
Clobazam—Feeling abnormal—Doxorubicin—ovarian cancer	0.000164	0.000857	CcSEcCtD
Clobazam—Urticaria—Doxorubicin—ovarian cancer	0.000158	0.000827	CcSEcCtD
Clobazam—Body temperature increased—Doxorubicin—ovarian cancer	0.000158	0.000822	CcSEcCtD
Clobazam—Asthenia—Epirubicin—ovarian cancer	0.000155	0.000807	CcSEcCtD
Clobazam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000154	0.00346	CbGpPWpGaD
Clobazam—Pruritus—Epirubicin—ovarian cancer	0.000152	0.000796	CcSEcCtD
Clobazam—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000152	0.00341	CbGpPWpGaD
Clobazam—Diarrhoea—Epirubicin—ovarian cancer	0.000147	0.000769	CcSEcCtD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—ovarian cancer	0.000145	0.00326	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000144	0.00322	CbGpPWpGaD
Clobazam—Asthenia—Doxorubicin—ovarian cancer	0.000143	0.000746	CcSEcCtD
Clobazam—Dizziness—Epirubicin—ovarian cancer	0.000142	0.000744	CcSEcCtD
Clobazam—Pruritus—Doxorubicin—ovarian cancer	0.000141	0.000736	CcSEcCtD
Clobazam—Vomiting—Epirubicin—ovarian cancer	0.000137	0.000715	CcSEcCtD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.000137	0.00307	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—YAP1—ovarian cancer	0.000136	0.00306	CbGpPWpGaD
Clobazam—Diarrhoea—Doxorubicin—ovarian cancer	0.000136	0.000712	CcSEcCtD
Clobazam—Rash—Epirubicin—ovarian cancer	0.000136	0.000709	CcSEcCtD
Clobazam—Dermatitis—Epirubicin—ovarian cancer	0.000136	0.000708	CcSEcCtD
Clobazam—SLC6A1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000135	0.00303	CbGpPWpGaD
Clobazam—Headache—Epirubicin—ovarian cancer	0.000135	0.000704	CcSEcCtD
Clobazam—SLC6A11—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000135	0.00302	CbGpPWpGaD
Clobazam—Dizziness—Doxorubicin—ovarian cancer	0.000132	0.000688	CcSEcCtD
Clobazam—SLC6A11—Neuronal System—MAPK1—ovarian cancer	0.000129	0.00288	CbGpPWpGaD
Clobazam—Nausea—Epirubicin—ovarian cancer	0.000128	0.000668	CcSEcCtD
Clobazam—Vomiting—Doxorubicin—ovarian cancer	0.000127	0.000662	CcSEcCtD
Clobazam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000126	0.00283	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000126	0.00282	CbGpPWpGaD
Clobazam—Rash—Doxorubicin—ovarian cancer	0.000126	0.000656	CcSEcCtD
Clobazam—Dermatitis—Doxorubicin—ovarian cancer	0.000126	0.000655	CcSEcCtD
Clobazam—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000125	0.0028	CbGpPWpGaD
Clobazam—Clozapine—CYP1B1—ovarian cancer	0.000125	0.274	CrCbGaD
Clobazam—Headache—Doxorubicin—ovarian cancer	0.000125	0.000652	CcSEcCtD
Clobazam—GABRB2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000121	0.00271	CbGpPWpGaD
Clobazam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.00012	0.0027	CbGpPWpGaD
Clobazam—Nausea—Doxorubicin—ovarian cancer	0.000118	0.000618	CcSEcCtD
Clobazam—GABRG2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000115	0.00258	CbGpPWpGaD
Clobazam—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000115	0.00257	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—FASN—ovarian cancer	0.000111	0.00249	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000111	0.00248	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—SLC5A5—ovarian cancer	0.000109	0.00245	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—NME2—ovarian cancer	0.000109	0.00244	CbGpPWpGaD
Clobazam—SLC6A1—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000109	0.00243	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—SLC2A1—ovarian cancer	0.000106	0.00237	CbGpPWpGaD
Clobazam—SLC6A1—Neuronal System—MAPK1—ovarian cancer	0.000104	0.00232	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—HRAS—ovarian cancer	0.000103	0.00231	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—CYP1B1—ovarian cancer	0.000101	0.00227	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000101	0.00226	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—TERT—ovarian cancer	9.83e-05	0.0022	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	9.66e-05	0.00216	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	9.55e-05	0.00214	CbGpPWpGaD
Clobazam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	9.27e-05	0.00208	CbGpPWpGaD
Clobazam—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	9.15e-05	0.00205	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PPP2R1A—ovarian cancer	8.98e-05	0.00201	CbGpPWpGaD
Clobazam—Ketazolam—ABCB1—ovarian cancer	8.8e-05	0.193	CrCbGaD
Clobazam—CYP2B6—Biological oxidations—CYP1B1—ovarian cancer	8.79e-05	0.00197	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	8.74e-05	0.00196	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—CYP1B1—ovarian cancer	8.67e-05	0.00194	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—ABCB1—ovarian cancer	8.34e-05	0.00187	CbGpPWpGaD
Clobazam—SLC6A1—Neuronal System—HRAS—ovarian cancer	8.32e-05	0.00186	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—TYMS—ovarian cancer	8.19e-05	0.00184	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	7.64e-05	0.00171	CbGpPWpGaD
Clobazam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	7.55e-05	0.00169	CbGpPWpGaD
Clobazam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	7.52e-05	0.00168	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CYTB—ovarian cancer	7.02e-05	0.00157	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	6.64e-05	0.00149	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—CAV1—ovarian cancer	6.6e-05	0.00148	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	6.55e-05	0.00147	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	6.54e-05	0.00147	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	6.37e-05	0.00143	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	6.16e-05	0.00138	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PPP1CC—ovarian cancer	6.14e-05	0.00138	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—BRIP1—ovarian cancer	6.14e-05	0.00138	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	6.11e-05	0.00137	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	6.09e-05	0.00136	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PIK3CG—ovarian cancer	6.01e-05	0.00135	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	5.98e-05	0.00134	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	5.85e-05	0.00131	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.83e-05	0.00131	CbGpPWpGaD
Clobazam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	5.78e-05	0.0013	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	5.63e-05	0.00126	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.63e-05	0.00126	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	5.6e-05	0.00126	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	5.57e-05	0.00125	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—NME2—ovarian cancer	5.36e-05	0.0012	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PIK3CD—ovarian cancer	5.29e-05	0.00118	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	5.28e-05	0.00118	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.12e-05	0.00115	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.1e-05	0.00114	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	5.07e-05	0.00114	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	5.05e-05	0.00113	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CASP3—ovarian cancer	5.05e-05	0.00113	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL2—ovarian cancer	5.05e-05	0.00113	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	4.96e-05	0.00111	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	4.95e-05	0.00111	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.92e-05	0.0011	CbGpPWpGaD
Clobazam—Clomipramine—ABCB1—ovarian cancer	4.92e-05	0.108	CrCbGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	4.91e-05	0.0011	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	4.89e-05	0.0011	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	4.87e-05	0.00109	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.86e-05	0.00109	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	4.85e-05	0.00109	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	4.82e-05	0.00108	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PIK3CB—ovarian cancer	4.61e-05	0.00103	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.58e-05	0.00103	CbGpPWpGaD
Clobazam—Flurazepam—ABCB1—ovarian cancer	4.57e-05	0.1	CrCbGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	4.47e-05	0.001	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.44e-05	0.000996	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	4.29e-05	0.000961	CbGpPWpGaD
Clobazam—Midazolam—ABCB1—ovarian cancer	4.24e-05	0.0929	CrCbGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.19e-05	0.000938	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—YAP1—ovarian cancer	4.12e-05	0.000922	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—NME2—ovarian cancer	4.05e-05	0.000907	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	3.99e-05	0.000895	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PTEN—ovarian cancer	3.98e-05	0.000892	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—NME2—ovarian cancer	3.95e-05	0.000885	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	3.94e-05	0.000882	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.91e-05	0.000876	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.89e-05	0.000871	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.83e-05	0.000858	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	3.74e-05	0.000839	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.68e-05	0.000824	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.66e-05	0.00082	CbGpPWpGaD
Clobazam—Diazepam—ABCB1—ovarian cancer	3.63e-05	0.0796	CrCbGaD
Clobazam—Clozapine—ABCB1—ovarian cancer	3.59e-05	0.0786	CrCbGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	3.54e-05	0.000793	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—MAPK1—ovarian cancer	3.51e-05	0.000786	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CYTB—ovarian cancer	3.45e-05	0.000774	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.43e-05	0.00077	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	3.43e-05	0.000769	CbGpPWpGaD
Clobazam—Chlorpromazine—ABCB1—ovarian cancer	3.37e-05	0.0739	CrCbGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.36e-05	0.000753	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—FASN—ovarian cancer	3.36e-05	0.000752	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—SLC5A5—ovarian cancer	3.3e-05	0.00074	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—MAPK1—ovarian cancer	3.21e-05	0.000719	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—SLC2A1—ovarian cancer	3.19e-05	0.000714	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	3.16e-05	0.000708	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CYP1B1—ovarian cancer	3.06e-05	0.000685	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PPP1CC—ovarian cancer	3.02e-05	0.000676	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—BRIP1—ovarian cancer	3.02e-05	0.000676	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.94e-05	0.000658	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—HRAS—ovarian cancer	2.82e-05	0.000631	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PIK3CA—ovarian cancer	2.81e-05	0.000629	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—MAPK1—ovarian cancer	2.8e-05	0.000628	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.8e-05	0.000627	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	2.75e-05	0.000616	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PPP2R1A—ovarian cancer	2.71e-05	0.000607	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CYTB—ovarian cancer	2.61e-05	0.000585	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—HRAS—ovarian cancer	2.58e-05	0.000577	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.56e-05	0.000573	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.55e-05	0.000571	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CYTB—ovarian cancer	2.55e-05	0.000571	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.54e-05	0.00057	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—ABCB1—ovarian cancer	2.52e-05	0.000564	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.49e-05	0.000559	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—TYMS—ovarian cancer	2.47e-05	0.000554	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.47e-05	0.000553	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—NME2—ovarian cancer	2.43e-05	0.000546	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.43e-05	0.000544	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.4e-05	0.000539	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.34e-05	0.000525	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—AKT1—ovarian cancer	2.29e-05	0.000514	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—BRIP1—ovarian cancer	2.28e-05	0.000511	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PPP1CC—ovarian cancer	2.28e-05	0.000511	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—HRAS—ovarian cancer	2.25e-05	0.000504	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PPP1CC—ovarian cancer	2.23e-05	0.000499	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—BRIP1—ovarian cancer	2.23e-05	0.000499	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.12e-05	0.000474	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—YAP1—ovarian cancer	2.02e-05	0.000454	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2e-05	0.000449	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CAV1—ovarian cancer	1.99e-05	0.000446	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.95e-05	0.000436	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.9e-05	0.000427	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.9e-05	0.000427	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PIK3CG—ovarian cancer	1.81e-05	0.000407	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.8e-05	0.000403	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.66e-05	0.000372	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.65e-05	0.00037	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—FASN—ovarian cancer	1.65e-05	0.00037	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—SLC5A5—ovarian cancer	1.62e-05	0.000364	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.6e-05	0.000358	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PIK3CD—ovarian cancer	1.59e-05	0.000357	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CYTB—ovarian cancer	1.57e-05	0.000352	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—SLC2A1—ovarian cancer	1.57e-05	0.000351	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—YAP1—ovarian cancer	1.53e-05	0.000343	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.51e-05	0.000339	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CYP1B1—ovarian cancer	1.5e-05	0.000337	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—YAP1—ovarian cancer	1.49e-05	0.000335	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PIK3CB—ovarian cancer	1.39e-05	0.000312	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.37e-05	0.000307	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.37e-05	0.000307	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.35e-05	0.000303	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	1.33e-05	0.000299	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.33e-05	0.000298	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—FASN—ovarian cancer	1.25e-05	0.000279	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—ABCB1—ovarian cancer	1.24e-05	0.000277	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.23e-05	0.000275	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—FASN—ovarian cancer	1.22e-05	0.000273	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—TYMS—ovarian cancer	1.22e-05	0.000272	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PTEN—ovarian cancer	1.2e-05	0.000269	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—SLC5A5—ovarian cancer	1.2e-05	0.000268	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—SLC2A1—ovarian cancer	1.18e-05	0.000265	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.16e-05	0.00026	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—SLC2A1—ovarian cancer	1.16e-05	0.000259	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CYP1B1—ovarian cancer	1.14e-05	0.000254	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CYP1B1—ovarian cancer	1.11e-05	0.000248	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.01e-05	0.000226	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1e-05	0.000225	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PPP2R1A—ovarian cancer	9.83e-06	0.00022	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CAV1—ovarian cancer	9.79e-06	0.000219	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—ABCB1—ovarian cancer	9.35e-06	0.00021	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—YAP1—ovarian cancer	9.2e-06	0.000206	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—TYMS—ovarian cancer	9.18e-06	0.000206	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—TYMS—ovarian cancer	8.96e-06	0.000201	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PIK3CG—ovarian cancer	8.92e-06	0.0002	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PIK3CA—ovarian cancer	8.48e-06	0.00019	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PIK3CD—ovarian cancer	7.84e-06	0.000176	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—FASN—ovarian cancer	7.5e-06	0.000168	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CAV1—ovarian cancer	7.4e-06	0.000166	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—SLC5A5—ovarian cancer	7.37e-06	0.000165	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CAV1—ovarian cancer	7.22e-06	0.000162	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—SLC2A1—ovarian cancer	7.12e-06	0.00016	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.07e-06	0.000158	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—AKT1—ovarian cancer	6.92e-06	0.000155	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PIK3CB—ovarian cancer	6.84e-06	0.000153	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CYP1B1—ovarian cancer	6.83e-06	0.000153	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PIK3CG—ovarian cancer	6.74e-06	0.000151	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PIK3CG—ovarian cancer	6.58e-06	0.000147	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	6.06e-06	0.000136	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PIK3CD—ovarian cancer	5.93e-06	0.000133	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PTEN—ovarian cancer	5.91e-06	0.000132	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PIK3CD—ovarian cancer	5.78e-06	0.00013	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—ABCB1—ovarian cancer	5.62e-06	0.000126	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—TYMS—ovarian cancer	5.52e-06	0.000124	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PIK3CB—ovarian cancer	5.17e-06	0.000116	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PIK3CB—ovarian cancer	5.04e-06	0.000113	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PTEN—ovarian cancer	4.46e-06	0.0001	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CAV1—ovarian cancer	4.45e-06	9.97e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PTEN—ovarian cancer	4.36e-06	9.76e-05	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PIK3CA—ovarian cancer	4.17e-06	9.34e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PIK3CG—ovarian cancer	4.05e-06	9.08e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.56e-06	7.99e-05	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—AKT1—ovarian cancer	3.4e-06	7.63e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PIK3CA—ovarian cancer	3.15e-06	7.06e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3.11e-06	6.96e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PIK3CA—ovarian cancer	3.07e-06	6.89e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PTEN—ovarian cancer	2.68e-06	6.01e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—AKT1—ovarian cancer	2.57e-06	5.76e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—AKT1—ovarian cancer	2.51e-06	5.63e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.89e-06	4.24e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—AKT1—ovarian cancer	1.55e-06	3.47e-05	CbGpPWpGaD
